Structure-activity relationships of sarafotoxins: chemical syntheses of chimera peptides of sarafotoxins S6b and S6c

Chikahisa Takasaki, Saburo Aimoto, Kazuhiro Kitazumi, Kenji Tasaka, Toshiharu Shiba, Katsuyuki Nishiki, Yasuo Furukawa, Ryoichi Takayanagi, Ohnaka Keizo, Hajime Nawata

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The three chimera peptides of sarafotoxins S6b (SRTb) and S6c (SRTc), [Thr2SRTb, [Asn4]SRTb and [Glu9]SRTb, were synthesized chemically. From the comparisons of lethality, vasoconstrictor activity and receptor binding activity of SRTb, SRTa ([Asn13]SRTb), SRTc ([Thr2Asn4Glu9Asn13]SRTb), [Thr2SRTb, [Asn4]SRTb and [Glu9SRTb, it appears that the Lys9 to Glu9 substitution greatly diminishes these activities while the Lys4 to Asn4 substitution does not affect them, and the Ser2 to Thr2 substitution or the Tyr13 to Asn13 substitution slightly diminishes these activities. There results suggest that the very low activities of SRTc are caused mainly by the Lys9 to Glu9 substitution, but not by the Ser2 to Thr2 substitution, which was suggested to be responsible for the weak bioactivities of SRTd ([Thr2,Ile19]SRTb).

Original languageEnglish
Pages (from-to)165-169
Number of pages5
JournalEuropean Journal of Pharmacology
Volume198
Issue number2-3
DOIs
Publication statusPublished - Jun 6 1991

Fingerprint

Structure-Activity Relationship
Peptides
sarafotoxins s6
Vasoconstrictor Agents

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Structure-activity relationships of sarafotoxins : chemical syntheses of chimera peptides of sarafotoxins S6b and S6c. / Takasaki, Chikahisa; Aimoto, Saburo; Kitazumi, Kazuhiro; Tasaka, Kenji; Shiba, Toshiharu; Nishiki, Katsuyuki; Furukawa, Yasuo; Takayanagi, Ryoichi; Keizo, Ohnaka; Nawata, Hajime.

In: European Journal of Pharmacology, Vol. 198, No. 2-3, 06.06.1991, p. 165-169.

Research output: Contribution to journalArticle

Takasaki, C, Aimoto, S, Kitazumi, K, Tasaka, K, Shiba, T, Nishiki, K, Furukawa, Y, Takayanagi, R, Keizo, O & Nawata, H 1991, 'Structure-activity relationships of sarafotoxins: chemical syntheses of chimera peptides of sarafotoxins S6b and S6c', European Journal of Pharmacology, vol. 198, no. 2-3, pp. 165-169. https://doi.org/10.1016/0014-2999(91)90616-X
Takasaki, Chikahisa ; Aimoto, Saburo ; Kitazumi, Kazuhiro ; Tasaka, Kenji ; Shiba, Toshiharu ; Nishiki, Katsuyuki ; Furukawa, Yasuo ; Takayanagi, Ryoichi ; Keizo, Ohnaka ; Nawata, Hajime. / Structure-activity relationships of sarafotoxins : chemical syntheses of chimera peptides of sarafotoxins S6b and S6c. In: European Journal of Pharmacology. 1991 ; Vol. 198, No. 2-3. pp. 165-169.
@article{318d364052f94ddd820a1f2facc8c250,
title = "Structure-activity relationships of sarafotoxins: chemical syntheses of chimera peptides of sarafotoxins S6b and S6c",
abstract = "The three chimera peptides of sarafotoxins S6b (SRTb) and S6c (SRTc), [Thr2SRTb, [Asn4]SRTb and [Glu9]SRTb, were synthesized chemically. From the comparisons of lethality, vasoconstrictor activity and receptor binding activity of SRTb, SRTa ([Asn13]SRTb), SRTc ([Thr2Asn4Glu9Asn13]SRTb), [Thr2SRTb, [Asn4]SRTb and [Glu9SRTb, it appears that the Lys9 to Glu9 substitution greatly diminishes these activities while the Lys4 to Asn4 substitution does not affect them, and the Ser2 to Thr2 substitution or the Tyr13 to Asn13 substitution slightly diminishes these activities. There results suggest that the very low activities of SRTc are caused mainly by the Lys9 to Glu9 substitution, but not by the Ser2 to Thr2 substitution, which was suggested to be responsible for the weak bioactivities of SRTd ([Thr2,Ile19]SRTb).",
author = "Chikahisa Takasaki and Saburo Aimoto and Kazuhiro Kitazumi and Kenji Tasaka and Toshiharu Shiba and Katsuyuki Nishiki and Yasuo Furukawa and Ryoichi Takayanagi and Ohnaka Keizo and Hajime Nawata",
year = "1991",
month = "6",
day = "6",
doi = "10.1016/0014-2999(91)90616-X",
language = "English",
volume = "198",
pages = "165--169",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Structure-activity relationships of sarafotoxins

T2 - chemical syntheses of chimera peptides of sarafotoxins S6b and S6c

AU - Takasaki, Chikahisa

AU - Aimoto, Saburo

AU - Kitazumi, Kazuhiro

AU - Tasaka, Kenji

AU - Shiba, Toshiharu

AU - Nishiki, Katsuyuki

AU - Furukawa, Yasuo

AU - Takayanagi, Ryoichi

AU - Keizo, Ohnaka

AU - Nawata, Hajime

PY - 1991/6/6

Y1 - 1991/6/6

N2 - The three chimera peptides of sarafotoxins S6b (SRTb) and S6c (SRTc), [Thr2SRTb, [Asn4]SRTb and [Glu9]SRTb, were synthesized chemically. From the comparisons of lethality, vasoconstrictor activity and receptor binding activity of SRTb, SRTa ([Asn13]SRTb), SRTc ([Thr2Asn4Glu9Asn13]SRTb), [Thr2SRTb, [Asn4]SRTb and [Glu9SRTb, it appears that the Lys9 to Glu9 substitution greatly diminishes these activities while the Lys4 to Asn4 substitution does not affect them, and the Ser2 to Thr2 substitution or the Tyr13 to Asn13 substitution slightly diminishes these activities. There results suggest that the very low activities of SRTc are caused mainly by the Lys9 to Glu9 substitution, but not by the Ser2 to Thr2 substitution, which was suggested to be responsible for the weak bioactivities of SRTd ([Thr2,Ile19]SRTb).

AB - The three chimera peptides of sarafotoxins S6b (SRTb) and S6c (SRTc), [Thr2SRTb, [Asn4]SRTb and [Glu9]SRTb, were synthesized chemically. From the comparisons of lethality, vasoconstrictor activity and receptor binding activity of SRTb, SRTa ([Asn13]SRTb), SRTc ([Thr2Asn4Glu9Asn13]SRTb), [Thr2SRTb, [Asn4]SRTb and [Glu9SRTb, it appears that the Lys9 to Glu9 substitution greatly diminishes these activities while the Lys4 to Asn4 substitution does not affect them, and the Ser2 to Thr2 substitution or the Tyr13 to Asn13 substitution slightly diminishes these activities. There results suggest that the very low activities of SRTc are caused mainly by the Lys9 to Glu9 substitution, but not by the Ser2 to Thr2 substitution, which was suggested to be responsible for the weak bioactivities of SRTd ([Thr2,Ile19]SRTb).

UR - http://www.scopus.com/inward/record.url?scp=0025852045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025852045&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(91)90616-X

DO - 10.1016/0014-2999(91)90616-X

M3 - Article

C2 - 1650701

AN - SCOPUS:0025852045

VL - 198

SP - 165

EP - 169

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -